Amid its multifront legal battle with Apple over its smartwatch’s blood oxygen sensors, Masimo has claimed new ground—including a significant…

Beacon Biosignals, known for its sleep monitoring system, hauled in $86 million as part of an oversubscribed series B funding…

Sanara MedTech dropped its Tissue Health Plus (THP) platform as part of an overall corporate realignment that focuses resources on…

Grail saw a sharp rise in third-quarter sales as it outlined a firmer FDA submission date for its Galleri cancer…

Promega has scored an FDA green light for its microsatellite instability testing technology as a companion diagnostic for Merck and…

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish company’s…

Molecular diagnostics firm BillionToOne raised $314 million in the DNA test maker’s upsized initial public offering but saw share values…

Guardant Health is touting the results of a new study showing its Reveal blood test can detect whether chemotherapy is…

Women’s health company Organon is selling off its postpartum uterine bleeding or hemorrhage system to Laborie Medical Technologies in a…

Synchron has reeled in another $200 million in a series D round—cash the company said it will use to expand…